keyword
https://read.qxmd.com/read/38631540/toxicity-evaluation-of-dose-escalation-in-hypofractionated-regional-nodal-irradiation-for-breast-cancer-a-retrospective-study
#21
JOURNAL ARTICLE
Euidam Kim, Ji Sung Yoo, Yeon-Joo Kim, Jungnam Joo, Eun Sang Oh, Yoonsun Chung, Seung Hyun Chung, Tae Hyun Kim
PURPOSE: Regional nodal irradiation (RNI) to the axilla and supraclavicular area presents distinct toxicities, such as lymphedema and shoulder stiffness, compared to whole-breast irradiation. There is insufficient evidence on the safety of dose-escalation in hypofractionated RNI. We aimed to evaluate and compare toxicity rates in patients with breast cancer who received hypofractionated RNI with and without dose-escalation. METHODS: We retrospectively analyzed 381 patients with breast cancer treated with hypofractionated RNI between March 2015 and February 2017...
April 15, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38628897/impact-of-dose-calculation-algorithms-and-radiobiological-parameters-on-prediction-of-cardiopulmonary-complications-in-left-breast-radiation-therapy
#22
JOURNAL ARTICLE
Niloofar Kargar, Ahad Zeinali, Mikaeil Molazadeh
BACKGROUND: Breast cancer requires evaluating treatment plans using dosimetric and biological parameters. Considering radiation dose distribution and tissue response, healthcare professionals can optimize treatment plans for better outcomes. OBJECTIVE: This study aimed to evaluate the effects of the different Dose Calculation Algorithms (DCAs) and Biologically Model-Related Parameters (BMRPs) on the prediction of cardiopulmonary complications due to left breast radiotherapy...
April 2024: Journal of Biomedical Physics & Engineering
https://read.qxmd.com/read/38627639/adenocarcinoma-originating-in-the-anterior-mediastinum-diagnosed-by-endobronchial-ultrasound-guided-transbronchial-cryobiopsy-a-case-report
#23
JOURNAL ARTICLE
Hiroyuki Tsuchida, Yuji Matsumoto, Hideaki Furuse, Takaaki Tsuchida
BACKGROUND: Endobronchial ultrasound-guided transbronchial cryobiopsy (EBUS-cryobiopsy) is advantageous for collecting larger specimens with minimal crushing; however, it has not been widely used for mediastinal tumors. CASE PRESENTATION: A 73-year-old woman with a history of left breast cancer underwent surgery followed by radiotherapy. Computed tomography showed a mass in the anterior mediastinum that was in extensive contact with the sternum on the ventral side and partly with the trachea on the dorsal side...
April 16, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38623966/intra-fractional-dose-rate-effect-in-continuous-and-interrupted-irradiation-of-the-mcf-7-cell-line-possible-radiobiological-implications-for-breath-hold-techniques-in-breast-radiotherapy
#24
JOURNAL ARTICLE
Mohammad Amin Mosleh-Shirazi, Somayeh Kazempour, Reza Fardid, Sedigheh Sharifzadeh, Sareh Karbasi
PURPOSE: To investigate the effects of different dose rates (DRs) in continuous and interrupted irradiation on in-vitro survival of the MCF-7 cell line, towards finding possible radiobiological effects of breath-hold techniques in breast radiotherapy (RT), in which intra-fractional beam interruptions and delivery prolongation can occur. MATERIALS AND METHODS: MCF-7 cells were irradiated continuously or with regular interruptions using 6 MV x-rays at different accelerator DRs (50-400 cGy/min) to deliver a 2 Gy dose...
April 6, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38623464/recurrent-invasive-ductal-carcinoma-of-the-breast-with-metastasis-to-the-uterine-cervix-a-case-report
#25
Alexander Dye, Vasanti Jhaveri, Savas Ozdemir, Ahmad Alkhasawneh, Karina Hew
This article presents a case of cervical metastasis from recurrence of invasive ductal carcinoma of the breast >20 years after initial diagnosis. The diagnosis was made after the patient presented with three months of intermittent post-menopausal vaginal spotting. She underwent palliative radiotherapy combined with chemotherapy and was disease free at the time of writing. Cervical metastasis of a primary breast cancer is extremely rare and can present with a variety of symptoms. This case report highlights the importance of life-long gynecologic care and surveillance in patients with a history of breast cancer...
June 2024: Case Reports in Women's Health
https://read.qxmd.com/read/38622132/microenvironmental-reorganization-in-brain-tumors-following-radiotherapy-and-recurrence-revealed-by-hyperplexed-immunofluorescence-imaging
#26
JOURNAL ARTICLE
Spencer S Watson, Benoit Duc, Ziqi Kang, Axel de Tonnac, Nils Eling, Laure Font, Tristan Whitmarsh, Matteo Massara, Bernd Bodenmiller, Jean Hausser, Johanna A Joyce
The tumor microenvironment plays a crucial role in determining response to treatment. This involves a series of interconnected changes in the cellular landscape, spatial organization, and extracellular matrix composition. However, assessing these alterations simultaneously is challenging from a spatial perspective, due to the limitations of current high-dimensional imaging techniques and the extent of intratumoral heterogeneity over large lesion areas. In this study, we introduce a spatial proteomic workflow termed Hyperplexed Immunofluorescence Imaging (HIFI) that overcomes these limitations...
April 15, 2024: Nature Communications
https://read.qxmd.com/read/38621608/impact-of-radiation-therapy-modalities-on-loco-regional-control-in-inflammatory-breast-cancer
#27
JOURNAL ARTICLE
Maximilien Rogé, Youlia Kirova, Emilie Lévêque, Marin Guigo, Alison Johnson, Rafik Nebbache, Eleonor Rivin Del Campo, Ioana Lazarescu, Stéphanie Servagi, Augustin Mervoyer, Axel Cailleteau, Sébastien Thureau, Juliette Thariat
INTRODUCTION: In inflammatory breast cancer (IBC), radiotherapy intensification is considered a standard of care by some teams, although the level of evidence remains low. We sought to analyze the impact of radiotherapy modalities on the risk of loco-regional and distant relapse. METHODS: A retrospective multicenter study included patients with localized IBC treated between 2010 and 2017. Standard post-mastectomy radiotherapy consisted of daily fractions to a total dose of 50 Gy equivalent without a boost or bolus, while intensified radiotherapy referred to the use of a boost or bolus...
April 13, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38616207/is-postmastectomy-radiotherapy-necessary-for-breast-cancer-patients-with-clinically-node-positive-downstaging-to-ypn0-after-neoadjuvant-chemotherapy
#28
JOURNAL ARTICLE
Chen-Feng Tan, Jun Wang, Xiao-Rong Zhong, Ze-Lei Dai, Zhong-Zheng Xiang, Yuan-Yuan Zeng, Xiao-Yuan Wei, Ning-Yue Xu, Lei Liu
PURPOSE: The significance of postmastectomy radiotherapy (PMRT) in breast cancer patients who initially have clinically node-positive (cN +) status but achieve downstaging to ypN0 following neoadjuvant chemotherapy (NAC) remains uncertain. This study aims to assess the impact of PMRT in this patient subset. METHODS: Patients were enrolled from West China Hospital, Sichuan University from 2008 to 2019. Overall survival (OS), Locoregional recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), and breast cancer-specific survival (BCSS) were estimated using the Kaplan-Meier method and assessed with the log-rank test...
April 15, 2024: Breast Cancer Research and Treatment
https://read.qxmd.com/read/38615873/recent-strategies-to-overcome-breast-cancer-resistance
#29
REVIEW
Muhammad Muzamil Khan, Satya Siva Kishan Yalamarty, Bharat Ashok Rajmalani, Nina Filipczak, Vladimir P Torchilin
Breast cancer is potentially a lethal disease and a leading cause of death in women. Chemotherapy and radiotherapy are the most frequently used treatment options. Drug resistance in advanced breast cancer limits the therapeutic output of treatment. The leading cause of resistance in breast cancer is endocrine and hormonal imbalance, particularly in triple negative and HER2 positive breast cancers. The efflux of drugs due to p-gp's activity is another leading cause of resistance. Breast cancer resistant protein also contributes significantly...
April 12, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38615593/implementing-supplementary-breast-cancer-screening-in-women-with-dense-breasts-insights-from-european-radiographers-and-radiologists
#30
JOURNAL ARTICLE
D Mizzi, C S Allely, F Zarb, C E Mercer
INTRODUCTION: In response to the critical need for enhancing breast cancer screening for women with dense breasts, this study explored the understanding of challenges and requirements for implementing supplementary breast cancer screening for such women among clinical radiographers and radiologists in Europe. METHOD: Fourteen (14) semi-structured online interviews were conducted with European clinical radiologists (n = 5) and radiographers (n = 9) specializing in breast cancer screening from 8 different countries: Denmark, Finland, Greece, Italy, Malta, the Netherlands, Switzerland, United Kingdom...
April 13, 2024: Radiography
https://read.qxmd.com/read/38614852/hypofractionation-for-regional-nodal-irradiation-in-breast-cancer-best-of-both-the-worlds
#31
REVIEW
Budhi Singh Yadav, Treshita Dey
Locoregional radiotherapy play an important role in controlling the disease after surgery in patients with breast cancer. Radiotherapy schedules vary from conventional fraction to hypofractionation. The purpose of this review is to get an insight into the data on regional nodal irradiation (RNI) with hypofractionation in patients with breast cancer. This systematic review was constructed in accordance with Preferred Reporting Items for Systematic reviews and Meta-analysis (PRISMA) framework. Electronic databases such as PubMed, Cochrane and EMBASE were searched from January 1, 2023 to March 31, 2023 to identify studies published in English language on hypofractionated RNI in post mastectomy patients...
March 14, 2024: Clinical Breast Cancer
https://read.qxmd.com/read/38614043/natural-products-and-derivatives-for-breast-cancer-treatment-from-drug-discovery-to-molecular-mechanism
#32
REVIEW
Jing Zhang, Yongya Wu, Yanhong Li, Shutong Li, Jiaxi Liu, Xiao Yang, Guiyang Xia, Guan Wang
BACKGROUND: Breast cancer stands as the most common malignancy among women globally and a leading cause of cancer-related mortality. Conventional treatments, such as surgery, hormone therapy, radiotherapy, chemotherapy, and small-molecule targeted therapy, often fall short of addressing the complexity and heterogeneity of certain breast cancer subtypes, leading to drug resistance and metastatic progression. Thus, the search for novel therapeutic targets and agents is imperative. Given their low toxicity and abundant variety, natural products and their derivatives are increasingly considered valuable sources for small-molecule anticancer drugs...
April 7, 2024: Phytomedicine
https://read.qxmd.com/read/38613358/radiosensitizing-effect-of-a-novel-ctss-inhibitor-by-enhancing-brca1-protein-stability-in-triple-negative-breast-cancer-cells
#33
JOURNAL ARTICLE
Eun Choi, Kyung-Hwa Jeon, Hanhee Lee, Gil-Im Mun, Jeong-Ahn Kim, Jae-Ho Shin, Youngjoo Kwon, Younghwa Na, Yun-Sil Lee
Triple-negative breast cancer (TNBC) patients harboring wild-type breast cancer susceptibility gene 1 (BRCA1) account for most TNBC patients but lack adequate targeted therapeutic options. Although radiotherapy (RT) is the primary treatment modality for TNBC patients, radioresistance is one of the major challenges. RT-induced increase in cathepsin S (CTSS) causes radioresistance through suppressing BRCA1-mediated apoptosis of tumor cells, which was induced by CTSS-mediated degradation of BRCA1. Targeting CTSS may provide a novel therapeutic opportunity for TNBC patients...
April 13, 2024: Cancer Science
https://read.qxmd.com/read/38611095/safety-of-the-breast-cancer-adjuvant-radiotherapy-in-ataxia-telangiectasia-mutated-variant-carriers
#34
JOURNAL ARTICLE
Rayan Bensenane, Arnaud Beddok, Fabienne Lesueur, Alain Fourquet, Mathilde Warcoin, Marine Le Mentec, Eve Cavaciuti, Dorothée Le Gal, Séverine Eon-Marchais, Nadine Andrieu, Dominique Stoppa-Lyonnet, Youlia Kirova
The Ataxia-Telangiectasia Mutated (ATM) gene is implicated in DNA double-strand break repair. Controversies in clinical radiosensitivity remain known for monoallelic carriers of the ATM pathogenic variant (PV). An evaluation of the single-nucleotide polymorphism (SNP) rs1801516 (G-A) showed different results regarding late subcutaneous fibrosis after breast radiation therapy (RT). The main objective of this study was to evaluate acute and late toxicities in carriers of a rare ATM PV or predicted PV and in carriers of minor allele A of rs1801516 facing breast RT...
April 5, 2024: Cancers
https://read.qxmd.com/read/38611085/further-clarification-of-pain-management-complexity-in-radiotherapy-insights-from-modern-statistical-approaches
#35
JOURNAL ARTICLE
Costanza Maria Donati, Erika Galietta, Francesco Cellini, Alessia Di Rito, Maurizio Portaluri, Cristina De Tommaso, Anna Santacaterina, Consuelo Tamburella, Filippo Mammini, Rossella Di Franco, Salvatore Parisi, Sabrina Cossa, Antonella Bianculli, Pierpaolo Ziccarelli, Luigi Ziccarelli, Domenico Genovesi, Luciana Caravatta, Francesco Deodato, Gabriella Macchia, Francesco Fiorica, Giuseppe Napoli, Silvia Cammelli, Letizia Cavallini, Milly Buwenge, Romina Rossi, Marco Maltoni, Alessio Giuseppe Morganti, Savino Cilla
BACKGROUND: The primary objective of this study was to assess the adequacy of analgesic care in radiotherapy (RT) patients, with a secondary objective to identify predictive variables associated with pain management adequacy using a modern statistical approach, integrating the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm and the Classification and Regression Tree (CART) analysis. METHODS: This observational, multicenter cohort study involved 1387 patients reporting pain or taking analgesic drugs from 13 RT departments in Italy...
April 3, 2024: Cancers
https://read.qxmd.com/read/38610216/tools-to-guide-radiation-oncologists-in-the-management-of-dcis
#36
REVIEW
Maria Cristina Leonardi, Maria Alessia Zerella, Matteo Lazzeroni, Nicola Fusco, Paolo Veronesi, Viviana Enrica Galimberti, Giovanni Corso, Samantha Dicuonzo, Damaris Patricia Rojas, Anna Morra, Marianna Alessandra Gerardi, Chiara Lorubbio, Mattia Zaffaroni, Maria Giulia Vincini, Roberto Orecchia, Barbara Alicja Jereczek-Fossa, Francesca Magnoni
Similar to invasive breast cancer, ductal carcinoma in situ is also going through a phase of changes not only from a technical but also a conceptual standpoint. From prescribing radiotherapy to everyone to personalized approaches, including radiotherapy omission, there is still a lack of a comprehensive framework to guide radiation oncologists in decision making. Many pieces of the puzzle are finding their place as high-quality data mature and are disseminated, but very often, the interpretation of risk factors and the perception of risk remain very highly subjective...
April 6, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/38609375/ruvbl1-ubiquitination-by-dtl-promotes-ruvbl1-2-%C3%AE-catenin-mediated-transcriptional-regulation-of-nhej-pathway-and-enhances-radiation-resistance-in-breast-cancer
#37
JOURNAL ARTICLE
Jie Tian, Mingxin Wen, Peng Gao, Maoxiao Feng, Guangwei Wei
Radiotherapy effectiveness in breast cancer is limited by radioresistance. Nevertheless, the mechanisms behind radioresistance are not yet fully understood. RUVBL1 and RUVBL2, referred to as RUVBL1/2, are crucial AAA+ ATPases that act as co-chaperones and are connected to cancer. Our research revealed that RUVBL1, also known as pontin/TIP49, is excessively expressed in MMTV-PyMT mouse models undergoing radiotherapy, which is considered a murine spontaneous breast-tumor model. Our findings suggest that RUVBL1 enhances DNA damage repair and radioresistance in breast cancer cells both in vitro and in vivo...
April 12, 2024: Cell Death & Disease
https://read.qxmd.com/read/38609112/the-effect-of-a-multimodal-approach-on-the-results-of-treatment-in-surgery-integration-of-chemotherapy-surgery-and-radiotherapy
#38
JOURNAL ARTICLE
V Vovk, I Duda, A Vovk
This study investigates the safety and efficacy of a multimodal approach, integrating radiotherapy, chemotherapy, and surgery for the management of cancer patients. This review systematically reviewed English-language literature from digital repositories, namely Web of Science, Scopus, Google Scholar, PubMed, and the Cochrane Library. The search strategy employed a targeted selection of keywords: "chemotherapy," "radiotherapy," "multimodal," and "surgery," encompassing publications published before January 2024...
February 2024: Georgian Medical News
https://read.qxmd.com/read/38607625/incidence-and-presenting-characteristics-of-angiosarcoma-in-the-us-2001-2020
#39
JOURNAL ARTICLE
Michael J Wagner, Vinod Ravi, Stephanie K Schaub, Ed Y Kim, Jeremy Sharib, Harveshp Mogal, Min Park, Michaela Tsai, Daniela Duarte-Bateman, Anthony Tufaro, Elizabeth T Loggers, Lee D Cranmer, Bonny Chau, Michael J Hassett, Juneko Grilley-Olson, Kelly G Paulson
IMPORTANCE: Angiosarcoma is an aggressive vascular malignant neoplasm presenting either as a primary or secondary cancer, often arising after radiotherapy or in the context of preexisting lymphedema. Comprehensive data describing its incidence and presentation patterns are needed. OBJECTIVE: To describe the incidence, presenting characteristics, and change over time of angiosarcoma in the US. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study used data from the US Cancer Statistics (USCS) National Program of Cancer Registries-Surveillance, Epidemiology, and End Results Combined Database, which captures more than 99% of newly diagnosed cancers in the US...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38607445/perceived-control-self-management-efficacy-and-quality-of-life-in-patients-treated-with-radiation-therapy-for-breast-cancer-a-longitudinal-study
#40
JOURNAL ARTICLE
Hai-Mei Qu, Hong-Yue Zhong, Tian Xiao, Yan-Jun Li, Pan Ren, Xiao-Ju Chen
OBJECTIVE: This longitudinal study aims to examine the present state of perceived control, self-management efficacy, and overall quality of life (QoL) in patients with breast cancer undergoing radiotherapy, and gain insight into the dynamic trends and factors that influence the quality of life experienced by patients during the course of radiotherapy. METHODS: Participants completed the Cancer Experience and Efficacy Scale (CEES), Strategies Used by People to Promote Health (SUPPH), and Functional Assessment of Cancer Therapy- Breast (FACT-B)...
April 12, 2024: Supportive Care in Cancer
keyword
keyword
43931
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.